Corcept Therapeutics CORT Short-term accrued government rebates
Other financials
Where this comes from
Reported directly by Corcept Therapeutics in its filing.
Tagged under the XBRL concept cort:AccruedGovernmentRebateCurrent.
The official record: Corcept Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corcept Therapeutics's short-term accrued government rebates.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corcept Therapeutics's short-term accrued government rebates?
- Corcept Therapeutics (CORT) reported short-term accrued government rebates of $33.56M in Q1 2026.
- How has Corcept Therapeutics's short-term accrued government rebates changed year-over-year?
- Corcept Therapeutics's short-term accrued government rebates decreased by 24.1% year-over-year, from $44.23M to $33.56M.
- What is the long-term trend for Corcept Therapeutics's short-term accrued government rebates?
- Over 5 years (2020 to 2025), Corcept Therapeutics's short-term accrued government rebates has grown at a 30.5% compound annual growth rate (CAGR), from $9.41M to $35.68M.